Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05269680 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

STAR-LIFE: a Post-market Registry on MINIject

Study acronym: STAR-LIFE
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 750 to 320v5 Show 5 more changesShow less
    • Primary and study completion dates: Jul 1, 2026 to Dec 2028
    • Primary endpoints: 3 to 1
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 1 to 15
    • Secondary endpoints expanded, about 37 words
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 30, 2022 to Jul 20, 2022
    v3
  4. Start date: Mar 1, 2022 to Apr 30, 2022v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
As part of the post-market clinical follow-up (PMCF), this registry is developed to ensure real-world data collection on MINIject device.
Trial Details
NCT Number NCT05269680
Lead Sponsor iSTAR Medical
Conditions
(from sponsor)		 Open Angle Glaucoma
Related terms Glaucoma, Open-Angle
Enrollment 320 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov